FDA, EU diverge on AstraZeneca's potential COVID-19 vaccine

ad+1

The FDA widened its probe into a serious illness linked to trials for AstraZeneca's potential COVID-19 vaccine, while in Europe the approval process has been fast-tracked.


from World - The Globe and Mail
Read The Rest:theglobeandmail...

0 comments: